Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTI-HUMAN CD22 MONOCLONAL ANTIBODIES AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/152282
Kind Code:
A1
Abstract:
CD22 antibodies, a preparation method therefor, and an application thereof. The CD22 antibodies have a high affinity to CD22 protein. Therefore, the CD22 antibodies can be used in the preparation of drugs for the treatment of diseases such as tumors and autoimmune diseases.

Inventors:
WANG QIONG (CN)
YANG CUIQING (CN)
CAO ZHUOXIAO (CN)
TANG RENHONG (CN)
REN JINSHENG (CN)
Application Number:
PCT/CN2022/072234
Publication Date:
July 21, 2022
Filing Date:
January 17, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
JIANGSU SIMCERE PHARM CO LTD (CN)
International Classes:
A61P35/00; A61K38/00; A61P7/00; C07K16/28; C12N15/13
Domestic Patent References:
WO2000067795A12000-11-16
Foreign References:
CN106029098A2016-10-12
CN103214578A2013-07-24
CN109970858A2019-07-05
CN103588882A2014-02-19
US20130142787A12013-06-06
CN109476747A2019-03-15
US20150239974A12015-08-27
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF: